Virtual opioid use disorder (OUD) therapy provider Bicycle Health has teamed up with telemedicine specialist Talkspace to expand access to care for patients battling addic
Indivior has secured a $111 million supply contract from the US federal government for its intranasal therapy for treating opioid overdose, in a further boost to the UK co
A test that can be given to patients before they are prescribed a course of opioid analgesics to check whether they are at risk of becoming dependent on the drugs has been
Emergent BioSolutions has confirmed that its over-the-counter (OTC) version of overdose reversal agent Narcan will be available on the shelves of pharmacies, grocery store
Addiction treatment specialist Spero Health has expanded an agreement to use Pear Therapeutics’ prescription digital therapeutics (DTx) in its network of US clinics.
UK-based pharma Indivior has agreed a takeover deal with Opiant Pharma that consolidates its position in the addiction treatment category with a new intranasal therapy, due to be filed with
South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.